Effect of recombinant human erythropoietin on plasma von Willebrand factor in chronic hemodialysis patients.
Hársfalvi
J
J
Boda
Z
Z
Mikita
J
J
Kárpáti
I
I
Kakuk
G
G
Rák
K
K
D003131:Combined Modality Therapy; D004921:Erythropoietin / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use; D006435:Renal Dialysis; D014511:Uremia / Q000097:blood* / Q000188:drug therapy / Q000628:therapy; D014841:von Willebrand Factor / Q000032:analysis*
D011994:Recombinant Proteins; D014841:von Willebrand Factor; D004921:Erythropoietin